Article

Redesigning your optical dispensary can boost its profitability

S

Of the diverse issues facing ophthalmology practices, one of the most hotly debated is launching and maintaining a profitable optical dispensary. What savvy ophthalmologists realize is that having a dispensary doesn't automatically improve patient satisfaction or the practice's bottom line. A successful optical dispensary takes management support and professional know-how to guide it.

In the quest to find a niche for your optical, simple, effective solutions often are overlooked. Changing the appearance of the optical dispensary is one such obvious option. A facelift can make a difference in the bottom line. In fact, this principle holds true in a variety of situations.

For example, last month I sold my home 10 days after placing it on the market for 5% above the appraised market value.
















"Why so fast?" you may ask.

Style and substance

Is your optical simply a patient convenience, or is it a part of your business in which you take great pride?

When I consult with a practice, my mental checklist covers housekeeping items as well as decorative touches.

Next, look at its outside entrance. Make sure the dispensary entrance area is immaculate and uncluttered. Is it sterile and abandoned-looking or warm and inviting? Is a direct phone number printed on the door, or is the door covered with a hodgepodge of crooked vendor decals? Use bright-colored flowers in handsome planters to decorate in spring and summer.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.